GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: This is an orally bioavailable, heterobifunctional PROTAC class degrader of the cyclin dependent kinase 2 (CDK2) protein [1]. CDK2 binding is mediated by a PF-06873600-derived moiety. This PROTAC mediates formation of a CDK2/Cyclin E1-cereblon (CRBN E3 ligase) ternary complex that is directed for proteasomal degradation. The PROTAC approach is proposed to act on CDK2-dependent tumours (e.g. with CCNE1 gene defects), and tumours with acquired resistance to CDK4/6 inhibitor therapies.
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Half-maximal degradation potency (DC50) is 17 nM in CCNE1nonamp TOV21G cells [1]. Maximum degradation (Dmax) is ~95% in cell-based assays. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||